White House announces 25 Cancer Moonshot initiatives, including $240M in ARPA-H funds

Thyme Care raises $97M in Series D investment

Thyme Care has announced a $97M Series D fundraise from current investors CVS Health Ventures, Foresite Capital, a16z Bio + Health, Concord Health Partners, Town Hall Ventures, AlleyCorp, and Frist Cressey Ventures. New strategic investors include Morgan Health, a division of JPMorganChase focused on employer-sponsored healthcare, as well as Humana, Texas Oncology, and Memorial Hermann Health System, bringing Thyme Care’s total capital raised to $275M.

October 03, 2025

Vol.51 No.36

In Brief

Shane Jacobson named CEO of the American Cancer Society, ACS CAN

Shane Jacobson was appointed CEO of the American Cancer Society and the American Cancer Society Cancer Action Network.

July 25, 2025

Vol.51 No.29

In Brief

Phyllis Harris appointed chief legal and risk officer at ACS

Phyllis Harris was appointed chief legal and risk officer of American Cancer Society, effective June 23.

June 27, 2025

Vol.51 No.25

In Brief

UNC Lineberger awarded up to $28M from ARPA-H to develop clinical trial for metastatic breast cancer

UNC Lineberger Comprehensive Cancer Center has been awarded up to $28 million by the Advanced Research Projects Agency for Health to lead the development of a next-generation clinical trial for breast cancer that has spread to other parts of the body.

June 20, 2025

Vol.51 No.24

In Brief

City of Hope awarded $23.7M from ARPA-H for biomarker mapping

City of Hope has been awarded an up to $23.7 million contract from the Advanced Research Projects Agency for Health within the U.S. Department of Health and Human Services. The grant will help City of Hope create a biomap of tumor changes that cause immunotherapy resistance in advanced or metastatic non-small cell lung cancer.

June 20, 2025

Vol.51 No.24

Clinical

Young women are now diagnosed with cancer at twice the rate of young men
The face of cancer is changing at a time when research is plagued by existential threats

For more than a year before her stage 4 lung cancer was found, 35-year-old Alisa Secaida, a never-smoker and a physically active Southern Californian, had been experiencing a persistent cough and, increasingly, fatigue.

June 06, 2025

Vol.51 No.22

By Claire Marie Porter

White House announces 25 Cancer Moonshot initiatives, including $240M in ARPA-H funds

YOU MAY BE INTERESTED IN

Thyme Care raises $97M in Series D investment

Shane Jacobson named CEO of the American Cancer Society, ACS CAN

Phyllis Harris appointed chief legal and risk officer at ACS

UNC Lineberger awarded up to $28M from ARPA-H to develop clinical trial for metastatic breast cancer

City of Hope awarded $23.7M from ARPA-H for biomarker mapping

Young women are now diagnosed with cancer at twice the rate of young men
The face of cancer is changing at a time when research is plagued by existential threats

Renew today!

Subscriber content

Never miss an issue!

Login

White House announces 25 Cancer Moonshot initiatives, including $240M in ARPA-H funds

YOU MAY BE INTERESTED IN

Thyme Care raises $97M in Series D investment

Shane Jacobson named CEO of the American Cancer Society, ACS CAN

Phyllis Harris appointed chief legal and risk officer at ACS

UNC Lineberger awarded up to $28M from ARPA-H to develop clinical trial for metastatic breast cancer

City of Hope awarded $23.7M from ARPA-H for biomarker mapping

Young women are now diagnosed with cancer at twice the rate of young menThe face of cancer is changing at a time when research is plagued by existential threats

Never miss an issue!

Login

Young women are now diagnosed with cancer at twice the rate of young men
The face of cancer is changing at a time when research is plagued by existential threats